Merrimack Pharmaceuticals
MACK
#7783
Rank
โ‚ฌ0.20 B
Marketcap
14,12ย โ‚ฌ
Share price
0.00%
Change (1 day)
22.00%
Change (1 year)

Merrimack Pharmaceuticals (MACK) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : โ‚ฌ21.15 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ21.15 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Merrimack Pharmaceuticals - Total liabilities on balance sheet (from 2010 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ0.39 M-27.35%
2022-12-31โ‚ฌ0.54 M10.65%
2021-12-31โ‚ฌ0.49 M-20.73%
2020-12-31โ‚ฌ0.62 M-74.68%
2019-12-31โ‚ฌ2.47 M-90.48%
2018-12-31โ‚ฌ25.98 M48.16%
2017-12-31โ‚ฌ17.53 M-94.48%
2016-12-31โ‚ฌ0.31 B-17.02%
2015-12-31โ‚ฌ0.38 B78.67%
2014-12-31โ‚ฌ0.21 B25.62%
2013-12-31โ‚ฌ0.17 B45.19%
2012-12-31โ‚ฌ0.11 B42.59%
2011-12-31โ‚ฌ82.38 M-60.37%
2010-12-31โ‚ฌ0.20 B9.13%
2009-12-31โ‚ฌ0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ56.77 B 268,264.94%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ67.55 M 219.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.13 B 529.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.71 B 3,272.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.33 M 142.64%๐Ÿ‡บ๐Ÿ‡ธ USA